Clinical trial
Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees
NCT00249379 · Virginia Commonwealth University, Other · Terminated
Key facts
| NCT number | NCT00249379 |
|---|---|
| Title | Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees |
| Official title | The Use of Acamprosate for Preventing Alcohol Relapse Among Alcohol Dependent Drug Treatment Court Participants |
| Lead sponsor | Virginia Commonwealth University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcohol Dependence |
| Intervention type | Drug |
| Interventions | Acamprosate |
| Enrollment | 26 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Nov 7, 2005 |
| Last update posted | May 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: